DRT, A WORLD LEADER IN PLANT CHEMISTRY AND A COMPANY OF THE FIRMENICH GROUP, CONFIRMS THE INVESTMENT IN A LARGE SCALE STATE-OF-THE-ART PLANT TO MANUFACTURE HYDROGENATED ROSIN AND RESIN DERIVATIVES, PLANS TO SIGNIFICANTLY INCREASE GLOBAL SUPPLY CAPABILITIES.
In September 2019, DRT laid out a plan to invest in a new production unit for highly hydrogenated rosin. The company today is pleased to announce that this large scale state-of-the-art facility is expected to be completed during the third quarter of 2022. The new plant, whose construction was initially delayed due to the Covid-19 pandemic, benefits from the financial support for industrial investment of the French Government as part of the “France Relance” recovery plan.
Located in Vielle Saint-Girons, South West of France, this new production unit will place DRT in a strategic position to address the anticipated growth in key industry segments. It will as well further strengthen the company’s global supply capabilities and will allow DRT to offer products with the highest degree of hydrogenation available on the market. The project also includes a hydrogenation pilot plant that has already been commissioned and is now fully operational.
This investment will uniquely position DRT as a global supplier of hydrogenated rosin and resin derivatives, with dual production capabilities in Europe and the US. This additional capacity will enable DRT to meet the growing demand for raw materials from natural origin in a variety of industry segments. It also contributes to Firmenich Ingredients ESG* Ambitions to become the number one company in renewable ingredients.
* Environmental, Social and Governance